In: Antimicrobial Agents and Chemotherapy, 2020, vol. 64, no. 2020-12, p. -
Metallo-β-lactamase (MBL)-producing Escherichia coli isolates resistant to the newly developed β-lactam/β-lactamase inhibitor drug combination aztreonam-avibactam (ATM-AVI) have been reported. Here, we analyzed a series of 118 clinical MBL- producing E. coli isolates of various geographical origins for susceptibility to ATM-AVI. The nature of the PBP3 protein sequence and the occurrence of...
|
In: Antimicrobial Agents and Chemotherapy, 2020, vol. 64, no. 4, p. -
Fosfomycin is gaining renewed interest for treating urinary tract infections. Monitoring fosfomycin resistance is therefore important in order to detect the emergence of novel resistance mechanisms. Here, we used the Rapid Fosfomycin NP test to screen a collection of extended-spectrum-β-lactamase- producing Escherichia coli isolates from Switzerland and found a fosfomycin- resistant isolate...
|
In: Journal of Clinical Microbiology, 2019, vol. 57, no. 1, p. e01531-18
The rapid fosfomycin/Escherichia coli NP test was developed to detect fosfomycin resistance in E. coli isolates. The test is based on glucose metabolization and the detection of bacterial growth in the presence of fosfomycin at 40 µg/ml. Bacterial growth is visually detectable by an orange-to-yellow color change of red phenol, a pH indicator. A total of 100 E. coli isolates, among which 22...
|
In: Microbiology Spectrum, 2018, vol. 6, no. 4, p. -
Multidrug resistance in Escherichia coli has become a worrying issue that is increasingly observed in human but also in veterinary medicine worldwide. E. coli is intrinsically susceptible to almost all clinically relevant antimicrobial agents, but this bacterial species has a great capacity to accumulate resistance genes, mostly through horizontal gene transfer. The most problematic...
|
In: Antonie van Leeuwenhoek, 2005, vol. 87, no. 2, p. 91-100
|
In: Biochemical Genetics, 2008, vol. 46, no. 1-2, p. 41-53
|
In: Applied Microbiology and Biotechnology, 2005, vol. 69, no. 3, p. 286-292
|
In: Applied Microbiology and Biotechnology, 2003, vol. 63, no. 3, p. 293-299
|
In: European Journal of Clinical Microbiology and Infectious Diseases, 2005, vol. 24, no. 3, p. 233-235
|
In: Applied Biochemistry and Biotechnology, 2011, vol. 163, no. 1, p. 71-79
|